It Beat a Statin 3 to 1 on Plaque: 46 Years of Nattokinase Research

In 1980, a researcher placed natto, a fermented soybean food Japan has eaten for about a thousand years, onto an artificial blood clot and watched it dissolve. Forty-six years later, the enzyme he found has 198 studies behind it across 43 diseases, including a randomized trial where plaque shrank 36.6% on nattokinase versus 11.5% on simvastatin. This visual deep dive covers how it works on clotting four different ways, whether it survives digestion, why dose explains the “negative” trial, blood pressure, neuroprotection, the spike protein, and the real bleeding risks when it’s stacked with other drugs.